vs

Side-by-side financial comparison of Dexcom (DXCM) and Lineage, Inc. (LINE). Click either name above to swap in a different company.

Lineage, Inc. is the larger business by last-quarter revenue ($1.4B vs $1.3B, roughly 1.1× Dexcom). Dexcom runs the higher net margin — 21.2% vs -7.3%, a 28.5% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 3.1%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Norwegian Cruise Line Holdings (NCLH) is a holding company that is based in the United States and domiciled in Bermuda. It operates three cruise lines as wholly owned subsidiaries: Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. With its subsidiaries combined, it is the third-largest cruise operator in the world. It is a publicly traded company listed on the New York Stock Exchange.

DXCM vs LINE — Head-to-Head

Bigger by revenue
LINE
LINE
1.1× larger
LINE
$1.4B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+18.4% gap
DXCM
21.6%
3.1%
LINE
Higher net margin
DXCM
DXCM
28.5% more per $
DXCM
21.2%
-7.3%
LINE

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
DXCM
DXCM
LINE
LINE
Revenue
$1.3B
$1.4B
Net Profit
$267.3M
$-100.0M
Gross Margin
62.9%
32.3%
Operating Margin
25.6%
2.5%
Net Margin
21.2%
-7.3%
Revenue YoY
21.6%
3.1%
Net Profit YoY
153.6%
79.4%
EPS (diluted)
$0.67
$-0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
LINE
LINE
Q1 26
$1.3B
Q4 25
$1.3B
Q3 25
$1.2B
$1.4B
Q2 25
$1.2B
$1.4B
Q1 25
$1.0B
$1.3B
Q4 24
$1.1B
$1.3B
Q3 24
$994.2M
$1.3B
Q2 24
$1.0B
$1.3B
Net Profit
DXCM
DXCM
LINE
LINE
Q1 26
$267.3M
Q4 25
$267.3M
Q3 25
$283.8M
$-100.0M
Q2 25
$179.8M
$-6.0M
Q1 25
$105.4M
$0
Q4 24
$151.7M
$-71.0M
Q3 24
$134.6M
$-485.0M
Q2 24
$143.5M
$-68.0M
Gross Margin
DXCM
DXCM
LINE
LINE
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
32.3%
Q2 25
59.5%
31.9%
Q1 25
56.9%
32.2%
Q4 24
58.9%
32.3%
Q3 24
59.7%
32.8%
Q2 24
62.4%
33.4%
Operating Margin
DXCM
DXCM
LINE
LINE
Q1 26
25.6%
Q4 25
25.6%
Q3 25
20.1%
2.5%
Q2 25
18.4%
1.7%
Q1 25
12.9%
4.3%
Q4 24
17.0%
-1.6%
Q3 24
15.3%
-38.6%
Q2 24
15.7%
5.5%
Net Margin
DXCM
DXCM
LINE
LINE
Q1 26
21.2%
Q4 25
21.2%
Q3 25
23.5%
-7.3%
Q2 25
15.5%
-0.4%
Q1 25
10.2%
Q4 24
13.6%
-5.3%
Q3 24
13.5%
-36.3%
Q2 24
14.3%
-5.1%
EPS (diluted)
DXCM
DXCM
LINE
LINE
Q1 26
$0.67
Q4 25
$0.67
Q3 25
$0.70
$-0.44
Q2 25
$0.45
$-0.03
Q1 25
$0.27
$0.01
Q4 24
$0.37
$-0.52
Q3 24
$0.34
$-2.44
Q2 24
$0.35
$-0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
LINE
LINE
Cash + ST InvestmentsLiquidity on hand
$917.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$8.4B
Total Assets
$6.3B
$19.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
LINE
LINE
Q1 26
$917.7M
Q4 25
$917.7M
Q3 25
$1.8B
Q2 25
$1.2B
Q1 25
$904.9M
Q4 24
$606.1M
$173.0M
Q3 24
$621.2M
$409.0M
Q2 24
$939.2M
$73.0M
Stockholders' Equity
DXCM
DXCM
LINE
LINE
Q1 26
$2.7B
Q4 25
$2.7B
Q3 25
$2.7B
$8.4B
Q2 25
$2.6B
$8.6B
Q1 25
$2.3B
$8.6B
Q4 24
$2.1B
$8.6B
Q3 24
$2.0B
$9.0B
Q2 24
$2.4B
$4.9B
Total Assets
DXCM
DXCM
LINE
LINE
Q1 26
$6.3B
Q4 25
$6.3B
Q3 25
$7.5B
$19.2B
Q2 25
$7.3B
$19.4B
Q1 25
$6.8B
$18.8B
Q4 24
$6.5B
$18.7B
Q3 24
$6.4B
$19.3B
Q2 24
$6.8B
$18.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
LINE
LINE
Operating Cash FlowLast quarter
$230.0M
Free Cash FlowOCF − Capex
$35.0M
FCF MarginFCF / Revenue
2.5%
Capex IntensityCapex / Revenue
14.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
LINE
LINE
Q1 26
Q4 25
$294.0M
Q3 25
$659.9M
$230.0M
Q2 25
$303.0M
$258.0M
Q1 25
$183.8M
$139.0M
Q4 24
$301.4M
Q3 24
$199.5M
$186.0M
Q2 24
$279.4M
$155.0M
Free Cash Flow
DXCM
DXCM
LINE
LINE
Q1 26
Q4 25
$192.1M
Q3 25
$579.4M
$35.0M
Q2 25
$208.9M
$95.0M
Q1 25
$96.8M
$-12.0M
Q4 24
$176.8M
Q3 24
$88.3M
$33.0M
Q2 24
$213.3M
$-31.0M
FCF Margin
DXCM
DXCM
LINE
LINE
Q1 26
Q4 25
15.3%
Q3 25
47.9%
2.5%
Q2 25
18.1%
7.0%
Q1 25
9.3%
-0.9%
Q4 24
15.9%
Q3 24
8.9%
2.5%
Q2 24
21.2%
-2.3%
Capex Intensity
DXCM
DXCM
LINE
LINE
Q1 26
Q4 25
8.1%
Q3 25
6.7%
14.2%
Q2 25
8.1%
12.1%
Q1 25
8.4%
11.7%
Q4 24
11.2%
Q3 24
11.2%
11.5%
Q2 24
6.6%
13.9%
Cash Conversion
DXCM
DXCM
LINE
LINE
Q1 26
Q4 25
1.10×
Q3 25
2.33×
Q2 25
1.69×
Q1 25
1.74×
Q4 24
1.99×
Q3 24
1.48×
Q2 24
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

LINE
LINE

Warehousing Operations$883.0M64%
Other$308.0M22%
Warehouse Lease$60.0M4%
Food Sales$52.0M4%
E Commerce And Other$46.0M3%
Railcar Lease$23.0M2%
Service Other$5.0M0%

Related Comparisons